Physician profile
Danny Isawi
NPI 1639585136
$3,951.26
in general payments reported to CMS, 2019-2025
39 companies · $822 in 2025
The $822 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $131 · 2021: $438 · 2022: $688 · 2023: $653 · 2024: $892 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,367.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $747.33 | 2019-2025 | |
| Glaxosmithkline, LLC. | $380.74 | 2019-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $323.08 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $269.08 | 2020-2025 | Eliquis, Camzyos |
| Amgen INC. | $244.37 | 2019-2025 | Evenity, Prolia, Repatha |
| Janssen Pharmaceuticals, INC | $171.42 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.78 | 2019-2025 | Jardiance |
| Abiomed | $158.17 | 2022-2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $154.74 | 2022-2025 | Farxiga |
| Abbvie INC. | $126.57 | 2023-2024 | |
| Dexcom, INC. | $96.65 | 2021-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $95.21 | 2021-2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $91.35 | 2022-2023 | |
| Exact Sciences Corporation | $88.29 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $85.69 | 2021-2025 | Zoryve |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Isawi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.